Cargando…

Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A

Intravesical botulinum toxin A (BoNTA) injection has been widely used for the treatment of detrusor overactivity in patients with neurogenic bladder due to spinal cord injury who do not respond to conventional treatment. There is no consensus about antibiotic prophylaxis for this procedure. We condu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paradella, Ana Claudia, Musegante, André Ferraz de Arruda, Brites, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427594/ https://www.ncbi.nlm.nih.gov/pubmed/27765580 http://dx.doi.org/10.1016/j.bjid.2016.08.012

Ejemplares similares

The role of botulinum toxin A in treating neurogenic bladder
por: Weckx, Filip, et al.
Publicado: (2016)

Botulinum Toxin-A Therapy in Pediatric Urology: Indications for the Neurogenic and Non-Neurogenic Neurogenic Bladder
por: Dyer, Lori, et al.
Publicado: (2009)

Pharmacotherapy in Pediatric Neurogenic Bladder Intravesical Botulinum Toxin Type A
por: Sager, Cristian, et al.
Publicado: (2012)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Clinical outcomes associated with guideline-discordant management of asymptomatic bacteriuria and urinary tract infection in hospitalized patients with neurogenic bladder
por: Fitzpatrick, Margaret A., et al.
Publicado: (2022)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
por: Wu, Shu-Yu, et al.
Publicado: (2021)

Antibiotic prophylaxis may not be necessary in patients with asymptomatic bacteriuria undergoing intradetrusor onabotulinumtoxinA injections for neurogenic detrusor overactivity
por: Leitner, Lorenz, et al.
Publicado: (2016)

Asymptomatic bacteriuria in recurrent UTI – to treat or not to treat
por: Cai, Tommaso, et al.
Publicado: (2017)

The necessity of treating asymptomatic bacteriuria with antibiotics in the perioperative period of joint arthroplasty: a metaanalysis.
por: JAMI, Sayed Abdulla, et al.
Publicado: (2021)

Asymptomatic Bacteriuria in Post Renal Transplant Patients: To Treat or Not?
por: Almaimani, Anas O
Publicado: (2021)

Cystoscopy and intravesical bacille Calmette–Guérin therapy in antibiotic-naïve patients with bladder cancer with asymptomatic bacteriuria: An update
por: Herr, Harry W.
Publicado: (2016)

Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
por: Cho, Young Sam, et al.
Publicado: (2016)

Botulinum toxin A improves neurogenic bladder fibrosis by suppressing transforming growth factor β1 expression in rats
por: Jia, Chunsong, et al.
Publicado: (2021)

219. Characteristics Associated with Inappropriate Antibiotic Prescribing in Patients with Asymptomatic Bacteriuria (ASB)
por: Bixby, Morgan L, et al.
Publicado: (2020)

A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
por: Vaughn, Valerie M., et al.
Publicado: (2023)

Quantifying the Implementation and Cost of a Multisite Antibiotic Stewardship Intervention for Asymptomatic Bacteriuria
por: Amenta, Eva, et al.
Publicado: (2023)

Asymptomatic bacteriuria among pregnant women
por: Imade, Paul Erhunmwunse, et al.
Publicado: (2010)

1676. Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
por: Kernan, Bailey, et al.
Publicado: (2020)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
por: Wu, Shang-Jun, et al.
Publicado: (2019)

Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016)

Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI
por: Cai, Tommaso, et al.
Publicado: (2016)

Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes
por: Phillips, Charles D, et al.
Publicado: (2012)

Analysis of an Antibiotic Stewardship Program for Asymptomatic Bacteriuria in the Veterans Affairs Health Care System
por: Grigoryan, Larissa, et al.
Publicado: (2022)

Sustained impact of an antibiotic stewardship initiative targeting asymptomatic bacteriuria and pyuria in the emergency department
por: Cash, Mary Catherine, et al.
Publicado: (2022)

Botulinum toxin in the management of acquired motor fusion deficiency
por: Murthy, Ramesh, et al.
Publicado: (2009)

Meta-Analysis of the Significance of Asymptomatic Bacteriuria in Diabetes
por: Renko, Marjo, et al.
Publicado: (2011)

The Paradigm Shift to Non-Treatment of Asymptomatic Bacteriuria
por: Nicolle, Lindsay E.
Publicado: (2016)

Association between Asymptomatic Bacteriuria and Pre-Eclampsia
por: Rezavand, Negin, et al.
Publicado: (2016)

Overtreatment of Asymptomatic Bacteriuria: A Qualitative Study
por: Eyer, Myriam, et al.
Publicado: (2015)

Asymptomatic bacteriuria in postmenopausal women with diabetes mellitus
por: Kasyan, George, et al.
Publicado: (2013)

Asymptomatic Bacteriuria in Pregnant Women in Outpatient Facilities
por: Nogayeva, Maral G., et al.
Publicado: (2015)

If you don’t test, they will not treat: Impact of stopping preoperative screening for asymptomatic bacteriuria
por: Winkler, Marisa L., et al.
Publicado: (2023)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Opportunities for antibiotic stewardship in emergency department or hospitalized patients with asymptomatic bacteriuria: identifying risk factors for antibiotic treatment
por: Bixby, Morgan L., et al.
Publicado: (2022)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017)

The use of botulinum toxin for the treatment of overactive bladder syndrome
por: Orasanu, Bogdan, et al.
Publicado: (2013)

1437. Safety and Effectiveness of a Laboratory Intervention to Reduce Antibiotic Consumption in Patients with Asymptomatic Bacteriuria
por: Mozafarihashjin, Mohammad, et al.
Publicado: (2019)

Exploration of Primary Care Clinician Attitudes and Cognitive Characteristics Associated With Prescribing Antibiotics for Asymptomatic Bacteriuria
por: Baghdadi, Jonathan D., et al.
Publicado: (2022)

Impact of Treating Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Prospective Cohort Study
por: Fontserè, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tm18gjv0n8s8bf3k16n6go5ao